Crossmark Global Holdings’s Immunocore IMCR Stock Holding History

Crossmark Global Holdings’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Sell	36,416 -41	-0.1%	-$1.21K	0.02%	591
2026 Q1	$1.1M	Buy	36,457 +51	+0.1%	+$1.65K	0.02%	584
2025 Q4	$1.26M	Buy	36,406 +58	+0.2%	+$2.05K	0.02%	543
2025 Q3	$1.32M	Buy	36,348 +3	+0%	+$102	0.02%	555
2025 Q2	$1.14M	Sell	36,345 -1,802	-5%	-$56K	0.02%	569
2025 Q1	$1.13M	Buy	38,147 +127	+0.3%	+$3.81K	0.02%	570
2024 Q4	$1.12M	Buy	38,020 +10,217	+37%	+$323K	0.02%	553
2024 Q3	$866K	Buy	+27,803	New	+$1.01M	0.02%	658

Other funds holding IMCR

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Crossmark Global Holdings's IMCR Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Immunocore (IMCR) stake by 0.11% in Q2 2026, selling an estimated $1.21K and leaving 36,416 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #591.

Crossmark Global Holdings first reported a position in IMCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.32M in Q3 2025. 13 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Crossmark Global Holdings held 36,416 shares of Immunocore worth $1.16M as of Q2 2026.
Crossmark Global Holdings sold 41 Immunocore shares in Q2 2026, an estimated $1.21K.
Immunocore made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #591 holding.
Crossmark Global Holdings first reported a position in Immunocore in Q3 2024 and has held it in 8 quarters since.
Crossmark Global Holdings's Immunocore position peaked at $1.32M in Q3 2025.
13 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.